--- title: "Radiopharmaceutical Manufacturing Unit" ocid: "ocds-h6vhtk-058bd9" canonical_url: "https://d3tenders.com/contract/?ocid=ocds-h6vhtk-058bd9" markdown_url: "https://d3tenders.com/contract/ocds-h6vhtk-058bd9.md" json_url: "https://d3tenders.com/contract/ocds-h6vhtk-058bd9.json" source: "Find A Tender Service" current_stage: "Planning" buyer: "GUY'S AND ST THOMAS' NHS FOUNDATION TRUST" published: "2025-08-21" --- # Radiopharmaceutical Manufacturing Unit Buyer: GUY'S AND ST THOMAS' NHS FOUNDATION TRUST Current stage: Planning OCID: ocds-h6vhtk-058bd9 [View canonical contract page](https://d3tenders.com/contract/?ocid=ocds-h6vhtk-058bd9) [Download OCDS JSON](https://d3tenders.com/contract/ocds-h6vhtk-058bd9.json) ## Summary Guy's and St Thomas' NHS Foundation Trust is currently in the planning stage for a public procurement process titled "Radiopharmaceutical Manufacturing Unit," which falls within the pharmacy and medical services industry category. The location pertains to London, within the United Kingdom. The procurement involves setting up an advanced GMP-compliant manufacturing unit, focused on radiopharmaceutical products, and is intended to address growing demand in the London area. A virtual market engagement event is scheduled for 19th September 2025, from 11:30 to 12:30, offering a panel discussion and outlining the procurement approach. Prospective businesses must confirm their participation by 17th September 2025, and further discussions will be available. The Managed Service Agreement (MSA) related to this initiative is anticipated to begin in June 2026, with the contract estimated at £42 million over 12 years, potentially extending to £69 million for an additional 5-year period. This procurement presents significant opportunities for businesses specialising in pharmacy, radiopharmaceuticals, and medical laboratory services. Companies with expertise in designing, building, and operating complex medical manufacturing facilities would likely benefit from competing for this Managed Service Agreement. As the initiative aims to integrate the new unit with existing NHS pathways and focus on education and clinical research, organizations with a strong commitment to innovation, regulatory compliance, and operational excellence are ideal candidates. This strategic move to enhance radiopharmaceutical services promises to bolster businesses aiming to expand their market presence within the healthcare sector and collaborate on cutting-edge medical advancements. ## Notice GSTT is seeking to commission an industry partner to design, build and operate a new, purpose-built Good Manufacturing Practice (GMP)-compliant Radiopharmaceutical Manufacturing Unit to support the growing demand for diagnostic (SPECT and PET) and therapeutic radiopharmaceuticals within close proximity of GSTT. It is anticipated a unit of 1,240 m2 within 1.5 miles of Guy's Hospital will be leased by GSTT and discussions with the landlord are progressing. This initiative aims to establish a hub-and-spoke model, where the new unit will serve as the central hub, and the existing facility at Guy's Hospital will continue as a spoke. This strategic development will: * Increase manufacturing capacity for routine diagnostics and advanced clinical trials for GSTT and for the wider London market. * Ensure equity of patient access to the latest RP diagnostics and therapeutics. * Support innovative clinical research. * Help future-proof Radiopharmacy services by adapting to evolving market demands. * Develop the Radiopharmacy workforce through education and training programmes to ensure they are equipped with the skills and expertise needed to meet the evolving demands of the industry. This initiative is part of GSTT's strategic vision to lead in nuclear medicine, enhancing patient access to advanced diagnostics and therapies while driving innovation in radiopharmaceutical production. The new unit will also serve as a centre for education and training, developing the next generation of radiopharmacists and strengthening GSTT's role as a leader in clinical research and healthcare excellence. The Estimated Total Contract Value including VAT detailed below is illustrative and VAT will only be charged if applicable. ### Planning Information 1 Introduction Guy’s and St Thomas’ NHS Foundation Trust (GSTT/the Trust) is pleased to announce an upcoming virtual market engagement event on Friday 19th September 2025 (11:30 – 12:30), in the form of a panel discussion with key stakeholders from GSTT. GSTT invites industry partners to participate in this engagement exercise to explore an exciting Managed Service Agreement (MSA) opportunity for the design, build and delivery of a Radiopharmacy Manufacturing Unit and Services for the Trust. This event aims to introduce the MSA opportunity, gather industry insights, and foster collaboration to shape the future of Radiopharmacy services at GSTT. 2 Objectives of the Market Engagement Event The panel discussion will: • Introduce the MSA opportunity and outline GSTT’s strategic vision for the new unit. • Test and refine the service model and financial framework to ensure alignment with supplier capabilities and market expectations. • Engage with industry stakeholders to gather insights and feedback on the procurement approach and specifications. • Foster collaboration and explore potential strategic partnerships with industry leaders. 3 Scope of the MSA Opportunity The MSA opportunity will encompass: • Design, build, and operation of a future-proofed state-of-the-art GMP-compliant Radiopharmaceutical Manufacturing Unit. • Aseptic manufacturing of diagnostic (SPECT and PET) and therapeutic radiopharmaceuticals for both routine use and clinical trials. • Production of investigational medicinal products (IMP) to support innovative clinical research. • Integration with existing GSTT pathways, ensuring high standards of patient safety and quality assurance. • Cell labelling services. This partnership will require operational excellence, regulatory compliance, and the ability to adapt to evolving market demands. It is anticipated the MSA contract will be awarded for a period of 12 years with an option to extend by a further 5 years. The contract value (exclusive of VAT) is estimated to be £42m for the first 12 years and £27m for the optional extension (total £69m) 4. Managed Service Agreement (MSA) A Managed Service Agreement (MSA) is a contract between an organisation (GSTT) and an external provider (the Supplier) to deliver and manage specific services or operations over an agreed period. Under an MSA, the supplier is responsible for end-to-end management, including staffing, equipment, maintenance, and compliance, ensuring that the service is delivered efficiently and consistently, in accordance with GSTT requirements. 5. Approach to procurement GSTT is planning to undertake a Competitive Flexible Procedure under the Procurement Act 2023 to select the right partner. To ensure transparency and gather industry insights, GSTT is hosting this virtual market engagement event to outline the project’s scope, expectations, and strategic direction. This will be followed by an opportunity for an individual meeting with GSTT to explore the opportunity in more detail. Please confirm your attendance by Wednesday 17th September 2025. ## Key Details | Field | Value | | --- | --- | | Publication source | Find A Tender Service | | Latest notice | https://www.find-tender.service.gov.uk/Notice/050413-2025 | | Notice type | UK2 - Preliminary Market Engagement Notice | | Procurement type | Standard | | Procurement category | Services | | Procurement method | Not Specified | | Procurement method details | Not specified | | Tender suitability | Not specified | | Awardee scale | Not specified | | All stages | Planning | ## Dates | Field | Value | | --- | --- | | Publication date | 21 Aug 2025 | | Submission deadline | Not specified | | Future notice date | 1 Oct 2025 | | Award date | Not specified | | Contract period | 31 May 2026 - 31 May 2038 | | Recurrence | Not specified | ## Values | Field | Value | | --- | --- | | Tender value | £69,000,000 | | Lots value | Not specified | | Awards value | Not specified | | Contracts value | Not specified | ## Status | Field | Value | | --- | --- | | Tender status | Planning | | Lots status | Planning | | Awards status | Not specified | | Contracts status | Not specified | ## Buyer | Field | Value | | --- | --- | | Main buyer | GUY'S AND ST THOMAS' NHS FOUNDATION TRUST | | Locality | LONDON | | Post town | South East London | | Postcode | SE1 9RT | | Country | England | | ITL 1 | TLI London | | ITL 2 | TLI4 Inner London - East | | ITL 3 | TLI44 Lewisham and Southwark | | Local authority | Southwark | | Electoral ward | London Bridge & West Bermondsey | | Westminster constituency | Bermondsey and Old Southwark | | Delivery location | TLI London | ## CPV Codes ### Divisions - 09 - Petroleum products, fuel, electricity and other sources of energy - 33 - Medical equipments, pharmaceuticals and personal care products - 85 - Health and social work services ### Codes - 09343000 - Radioactive materials - 33124000 - Diagnostics and radiodiagnostic devices and supplies - 33140000 - Medical consumables - 33151000 - Radiotherapy devices and supplies - 33151400 - Radiotherapy supplies - 33600000 - Pharmaceutical products - 33694000 - Diagnostic agents - 85145000 - Services provided by medical laboratories - 85149000 - Pharmacy services ## Release History - 21 Aug 2025 at 09:13 - Planning - UK2 - Preliminary Market Engagement Notice - https://www.find-tender.service.gov.uk/Notice/050413-2025 ## Documents - https://www.find-tender.service.gov.uk/Notice/050413-2025 21st August 2025 - Preliminary market engagement notice on Find a Tender ## Notice URLs - https://www.guysandstthomas.nhs.uk - https://www.legislation.gov.uk/ukpga/2023/54/contents ## Provenance This Markdown file is an alternate public rendering of the D3 Tenders contract record. The canonical page is https://d3tenders.com/contract/?ocid=ocds-h6vhtk-058bd9. The underlying structured data is available as OCDS JSON at https://d3tenders.com/contract/ocds-h6vhtk-058bd9.json.